黑素补充剂对癌症相关疲劳的影响:随机对照试验的元分析
Yongchao Li1, Wencai Zhang1, Xiaochun Zeng2
1Department of Rehabilitation, The First People's Hospital of Chenzhou, Chenzhou, Hunan, China.
概括
补充黑素可能有助于减少与癌症相关的疲劳 (CRF). 较长的干预持续时间为13周或更长的时间显示,癌症患者的疲劳症状显著改善.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 睡眠医学 睡眠医学
背景情况:
- 与癌症相关的疲劳 (CRF) 是癌症及其治疗的常见和衰弱的副作用.
- 之前对黑激素在治疗CRF的有效性进行的研究已经产生了不一致的结果.
- 需要进行系统评估,以澄清黑激素对癌症患者疲劳的影响.
研究的目的:
- 系统地评估黑素补充剂对癌症患者疲劳严重性的影响.
- 综合随机对照试验 (RCT) 的证据,以确定黑色素对CRF的有效性.
主要方法:
- 在PubMed,Embase和Cochrane图书馆数据库中进行了全面的文献搜索.
- 包括的研究是以英语出版的随机对照试验 (RCT).
- 在元分析中使用随机效应模型将研究结果结合起来.
主要成果:
- 在分析中包括了9个RCT.
- 与安慰剂相比,补充黑色素显著改善了疲劳症状 (SMD: -0.23,p=0.04).
- 治疗持续时间是一个重要因素,在持续≥13周的干预措施中观察到改善 (SMD: -0.38),但没有更短的持续时间 (SMD: 0.06).
结论:
- 补充黑素显示出缓解与癌症相关的疲劳的潜力.
- 黑激素对CRF的疗效似乎取决于干预的持续时间,更长的时间 (≥13周) 更有效.
相关概念视频
Management of Insomnia
181
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
181
mTOR Signaling and Cancer Progression
3.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.6K
Drugs that Stabilize Microtubules
1.9K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
1.9K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Circadian Rhythms and Gene Regulation
4.0K
The biological clock is involved in many aspects of regulating complex physiology in all animals. It was in 1935 when German zoologists, Hans Kalmus and Erwin Bünning, discovered the existence of circadian rhythm in Drosophila melanogaster. However, the internal molecular mechanisms behind the circadian clock remained a mystery until 1984, when Jeffrey C. Hall, Michael Rosbash, and Michael W. Young discovered the expression of the Per gene oscillating over a 24-hour cycle. In subsequent...
4.0K
Cancer Survival Analysis
290
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
290


